Regulatory approval of pharmaceuticals without a randomised controlled study: analysis of EMA and FDA approvals 1999-2014
about
Different Weights of the Evidence-Based Medicine Triad in Regulatory, Health Technology Assessment, and Clinical Decision Making.Economic Evaluations of Pharmaceuticals Granted a Marketing Authorisation Without the Results of Randomised Trials: A Systematic Review and Taxonomy.Availability of evidence of benefits on overall survival and quality of life of cancer drugs approved by European Medicines Agency: retrospective cohort study of drug approvals 2009-13.How do we avoid disaster when exiting the European Medicines Agency? Making the most of Brexit in pharmaceutical regulation.Balancing early access with uncertainties in evidence for drugs authorized by prospective case series - systematic review of reimbursement decisions.Augmenting endogenous repair of soft tissues with nanofibre scaffolds.
P2860
Regulatory approval of pharmaceuticals without a randomised controlled study: analysis of EMA and FDA approvals 1999-2014
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 June 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Regulatory approval of pharmac ...... MA and FDA approvals 1999-2014
@en
Regulatory approval of pharmac ...... A and FDA approvals 1999-2014.
@nl
type
label
Regulatory approval of pharmac ...... MA and FDA approvals 1999-2014
@en
Regulatory approval of pharmac ...... A and FDA approvals 1999-2014.
@nl
prefLabel
Regulatory approval of pharmac ...... MA and FDA approvals 1999-2014
@en
Regulatory approval of pharmac ...... A and FDA approvals 1999-2014.
@nl
P2093
P2860
P1433
P1476
Regulatory approval of pharmac ...... MA and FDA approvals 1999-2014
@en
P2093
Anthony J Hatswell
Jesse A Berlin
Nick Freemantle
P2860
P304
P356
10.1136/BMJOPEN-2016-011666
P577
2016-06-30T00:00:00Z